Marshall Lutske, MD
Vascular Surgery · Snellville, GANPI 1083931406
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 65.7% of it on its own, with 38 other manufacturers making up the rest. Among vascular surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $134.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$27K
- Inari Medical, Inc.$4K
- W. L. Gore & Associates, Inc.$4K
- Endologix LLC$865
- Silk Road Medical, Inc.$650
- Shockwave Medical, Inc$550
- plus $4K from 33 others
What the payments were for
- Consulting fees$12,40030%
- Travel & lodging$11,58928%
- Food & beverage$16,65841%
- Education$640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 162 | $26,747 |
| Inari Medical, Inc. | 15 | $4,460 |
| W. L. Gore & Associates, Inc. | 34 | $3,737 |
| Endologix LLC | 3 | $865 |
| Silk Road Medical, Inc. | 7 | $650 |
| Shockwave Medical, Inc | 8 | $550 |
| Penumbra, Inc. | 3 | $409 |
| Medtronic | 7 | $346 |
| Cook Medical LLC | 7 | $314 |
| Edwards Lifesciences | 1 | $303 |
| Angiodynamics, Inc. | 8 | $262 |
| Johnson & Johnson(2 entities) | 8 | $239 |
| Stryker | 2 | $220 |
| Bard Peripheral Vascular, Inc. | 4 | $218 |
| Smith+Nephew | 3 | $216 |
| Lemaitre Vascular, Inc. | 4 | $170 |
| Terumo Medical Corporation | 1 | $170 |
| Cvrx, Inc. | 1 | $137 |
| Teleflex LLC | 2 | $115 |
| Reflow Medical Inc | 1 | $111 |
| Baxter Healthcare | 1 | $52 |
| Mimedx Group, Inc. | 3 | $47 |
| Kerecis Limited | 1 | $32 |
| Imperative Care, Inc | 1 | $31 |
| Organogenesis Inc. | 1 | $29 |
| Pfizer | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $24 |
| Abbott | 1 | $24 |
| Polynovo North America LLC | 1 | $24 |
| Cashflow Solutions, LLC | 1 | $23 |
| Veryan Medical Incorporated | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Truvic Medical, Inc. | 1 | $18 |
| Amgen | 1 | $18 |
| My01 Inc. | 1 | $18 |
| Sirtex Medical Inc | 1 | $17 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Hydrofera LLC | 1 | $14 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$6,423
- FLOWTRIEVER CATHETER, S$4,334
- CT THROMBECTOMY SYSTEM KIT$4,334
- GENERAL VASCULAR INTERVENTION$2,265
- ENROUTE Transcarotid Neuroprotection System$838
- AFX2 Bifurcated Endograft System$796
- GENERAL ANGIOGRAPHY$787
- GORE VIABAHN VBX Balloon Expandable Endo$705
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$664
- ENROUTE Transcarotid Stent$499
- GORE EXCLUDER Iliac Branch Endoprosthesis$458
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$396
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$339
- GORE TAG Thoracic Endoprosthesis$337
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$309
- Azur CX Detachable$170
- GORE VIABAHN Endoprosthesis$168
- ROTAPRO$161
- Micra$159
- Indigo System$150
How this compares
$40,711 in reported general payments places this provider in the 90th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $56,970 |
| XareltoRivaroxaban | 15 | $13,728 |
| ClopidogrelClopidogrel Bisulfate | 60 | $569 |
| Cilostazol | 30 | $272 |
| Atorvastatin Calcium | 26 | $192 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $108 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $25 | $56,97071 claims |
| Johnson & JohnsonXarelto | $239 | $13,72815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Snellville
- Siddharth PatelAtlanta$303K
- Juan AyerdiColumbus$130K
- Albert RichardsonThomasville$103K
- Walaya Methodius-RayfordAtlanta$79K
- Eric MartinFort Gordon$64K
- William JordanAugusta$64K
- Alykhan LalaniMarietta$64K
- Charles MoomeyGainesville$52K
- Suman AnnambhotlaGainesville$48K
- Andrew UnzeitigAtlanta$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.